| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.442 | 16.177 | 15.721 | 17.459 | 15.018 | 8.184 |
| Total Income - EUR | - | - | - | - | 3.442 | 16.177 | 15.721 | 19.422 | 15.018 | 8.184 |
| Total Expenses - EUR | - | - | - | - | 42 | 1.331 | 1.168 | 2.366 | 1.372 | 711 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.400 | 14.846 | 14.553 | 17.056 | 13.646 | 7.473 |
| Net Profit/Loss - EUR | - | - | - | - | 3.297 | 14.397 | 14.090 | 16.543 | 11.526 | 6.457 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Caligyn Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 196 | 0 | 0 | 905 | 644 | 385 |
| Current Assets | - | - | - | - | 3.563 | 14.697 | 14.554 | 15.759 | 11.756 | 10.903 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 10.373 | 4 | 0 | 6.671 | 0 |
| Cash | - | - | - | - | 3.563 | 4.323 | 14.550 | 15.759 | 5.085 | 10.903 |
| Shareholders Funds | - | - | - | - | 3.339 | 14.447 | 14.139 | 16.591 | 11.575 | 11.332 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 419 | 284 | 586 | 267 | 826 | 212 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Caligyn Med S.r.l.